Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP504241.RAoUn5NKDfSNImn9rYwWvKwytn6KOQY9KBTcPf7Sn9dP0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP504241.RAoUn5NKDfSNImn9rYwWvKwytn6KOQY9KBTcPf7Sn9dP0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP504241.RAoUn5NKDfSNImn9rYwWvKwytn6KOQY9KBTcPf7Sn9dP0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP504241.RAoUn5NKDfSNImn9rYwWvKwytn6KOQY9KBTcPf7Sn9dP0130_provenance.
- NP504241.RAoUn5NKDfSNImn9rYwWvKwytn6KOQY9KBTcPf7Sn9dP0130_assertion description "[These results demonstrate that the selective alpha(1)-adrenergic receptor antagonist dox inhibits pituitary tumor cell growth in vitro and in vivo by mechanisms that are in part independent of its alpha-adrenergic receptor-blocking actions and involve down-regulation of nuclear factor-kappaB signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP504241.RAoUn5NKDfSNImn9rYwWvKwytn6KOQY9KBTcPf7Sn9dP0130_provenance.
- NP504241.RAoUn5NKDfSNImn9rYwWvKwytn6KOQY9KBTcPf7Sn9dP0130_assertion evidence source_evidence_literature NP504241.RAoUn5NKDfSNImn9rYwWvKwytn6KOQY9KBTcPf7Sn9dP0130_provenance.
- NP504241.RAoUn5NKDfSNImn9rYwWvKwytn6KOQY9KBTcPf7Sn9dP0130_assertion SIO_000772 16020484 NP504241.RAoUn5NKDfSNImn9rYwWvKwytn6KOQY9KBTcPf7Sn9dP0130_provenance.
- NP504241.RAoUn5NKDfSNImn9rYwWvKwytn6KOQY9KBTcPf7Sn9dP0130_assertion wasDerivedFrom befree-2016 NP504241.RAoUn5NKDfSNImn9rYwWvKwytn6KOQY9KBTcPf7Sn9dP0130_provenance.
- NP504241.RAoUn5NKDfSNImn9rYwWvKwytn6KOQY9KBTcPf7Sn9dP0130_assertion wasGeneratedBy ECO_0000203 NP504241.RAoUn5NKDfSNImn9rYwWvKwytn6KOQY9KBTcPf7Sn9dP0130_provenance.
- befree-2016 importedOn "2016-02-19" NP504241.RAoUn5NKDfSNImn9rYwWvKwytn6KOQY9KBTcPf7Sn9dP0130_provenance.